SYNAPSET
LIVE

Serial Number

87431283

Owner

Bioflash inc

Attorney

Jess M. Collen

Filing Date

Apr 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

SYNAPSET Trademark

Serial Number: 87431283 • Registration: 5558464

SYNAPSET is a trademark filed by Bioflash inc on April 30, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bioflash inc (4 trademarks)

748 Blvd Veterans
Sherbrooke J1N 1Z7 , CA

Entity Type: 03

Trademark Details

Filing Date

April 30, 2017

Registration Date

September 11, 2018

Published for Opposition

June 26, 2018

Goods & Services

[ Beverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; ] Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; ] Dietary [ and nutritional ] supplements containing fish oils, minerals, vitamins [ , plant oil; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements also containing minerals, vitamins, oils; Dietary supplements for human consumption ] ; Dietary supplements for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Dietetic foods for treating attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Edible fish oils, mineral preparations, vitamins, and medicinal plant oils adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of pharmaceutical preparations; Edible fish oils for medical purposes; Food supplements; Food supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Gummy vitamins; Liquid nutritional supplement; Liquid vitamin supplements; Medicaments for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson 's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicated water for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicinal drinks; Migraine treatment preparations; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed vitamin preparations; Multi-vitamin preparations ] ; Multivitamin preparations; [ Natural dietary supplements; Natural dietary supplements for the treatment of attentiondeficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Natural supplements for treating depression and anxiety; Nutraceuticals for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutraceuticals for use as a dietary supplement; ] Nutraceuticals for use as a dietary supplement for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement shakes; Nutritional supplements ] ; Nutritional supplements consisting primarily of Omega3 oil, vitamins, vitamin B6, minerals, zinc, magnesium [ ; Nutritional supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional supplements in the form of powder, liquid, capsules, tablets, gel; Nutritional supplements, namely, probiotic compositions; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment and prevention of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for treating chemical imbalances; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix containing fish oils, vitamins, minerals, plant oils; Therapeutic pharmaceutical for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin and mineral supplements for mixing with food and beverages; Vitamin B preparations; Vitamin fortified beverages for medical purposes; Vitamin preparations; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 16, 2025 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 16, 2025 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 16, 2025 APRE
TEAS SECTION 8 RECEIVED
Mar 7, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 11, 2023 REM1
TTAB RELEASE CASE TO TRADEMARKS
Aug 20, 2019 TMBN
CANCELLATION TERMINATED NO. 999999
Aug 20, 2019 CANT
CANCELLATION DENIED NO. 999999
Aug 20, 2019 CAND
CANCELLATION INSTITUTED NO. 999999
Oct 1, 2018 PETC
REGISTERED-PRINCIPAL REGISTER
Sep 11, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 26, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 26, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 6, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 23, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 18, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2018 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2018 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2018 CNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2018 CNRT
REMOVED FROM TEAS PLUS
Mar 16, 2018 RFTP
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2018 CRFA
ASSIGNED TO LIE
Feb 28, 2018 ALIE
NOTICE OF REVIVAL - E-MAILED
Feb 16, 2018 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2018 TROA
PETITION TO REVIVE-GRANTED
Feb 15, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 15, 2018 PROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 3, 2017 GPRN
PRIORITY ACTION E-MAILED
Aug 3, 2017 GPRA
PRIORITY ACTION WRITTEN
Aug 3, 2017 CPRA
ASSIGNED TO EXAMINER
Jul 27, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2017 NWOS
NEW APPLICATION ENTERED
May 3, 2017 NWAP